Loading...
XLON
AMS
Market cap808mUSD
Oct 09, Last price  
282.00GBP
1D
0.36%
1Q
1.25%
Jan 2017
27.40%
IPO
3,263.10%
Name

Advanced Medical Solutions Group PLC

Chart & performance

D1W1MN
XLON:AMS chart
P/E
61.31
P/S
2.67
EPS
0.05
Div yield, %
0.95%
Shrs. gr., 5y
0.20%
Rev. gr., 5y
21.41%
Revenues
229m
+28.96%
14,322,00016,856,00020,316,00024,091,00031,881,00034,353,00052,589,00059,499,00063,010,00068,596,00083,242,00096,908,000102,598,000102,368,00086,796,000108,601,000124,330,000126,210,000177,521,000228,936,000
Net income
10m
+40.32%
747,0002,236,0003,309,0002,784,0004,833,0004,850,0009,692,00011,366,00012,864,00014,119,00015,692,00020,134,00022,650,00018,919,0008,584,00017,481,00020,406,00015,889,0007,094,0009,954,000
CFO
29m
+47.51%
1,479,0003,671,0002,740,0002,026,0007,010,0004,849,00011,893,00014,070,00016,572,00021,291,00019,825,00016,966,00021,674,00021,412,00021,053,00030,409,00027,080,00012,345,00019,489,00028,749,000
Dividend
May 28, 20262.01 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Advanced Medical Solutions Group plc (AMS), along with its subsidiaries, specializes in the innovation, production, and worldwide distribution of advanced medical solutions. Its primary markets include wound treatment, surgical procedures, and wound closure, with a significant presence across the United Kingdom, Germany, France, wider Europe, the United States, and other international regions. The company's operations are structured into two main divisions: Surgical and Woundcare. The Surgical segment provides a comprehensive range of specialized products. These include topical tissue adhesives for sealing and closing wounds, offered under the LiquiBand brand; sutures and collagen-derived materials for surgical and dental applications, marketed as RESORBA; various collagen products; the LiquiBand Fix8 laparoscopic device designed for internally securing hernia meshes; and internal sealants available under the Seal-G and Seal-G MIST brands. Conversely, the Woundcare segment focuses on a broad spectrum of sophisticated wound management technologies. Its offerings comprise alginates, medical foams, films, fibers, hydrogels, antimicrobial dressings, and hydrocolloids, alongside a dedicated line of wound care products under the ActivHeal brand. Established in 1991, Advanced Medical Solutions Group plc maintains its corporate headquarters in Winsford, United Kingdom.

Key people

Non-Executive Chairman of the Board · since 2014
Eddie Johnson
Chief Financial Officer, Group Financial Controller, Director · since 2018
Alan Richardson
Chief Operating Officer · since 2018
Cathy Tomlinson
Group Human Resources Director · since 2017
Simon Coates
Group Manager - IS · since 2015
Rose Guang
Director - Group Quality Assurance/Regulatory Affairs (QA/RA) · since 2013
Pieter Van-Hoof
Director - Group Operations · since 2016
Becky Walmsley
Business Unit Director - OEM and Bulk Materials · since 2015
Jeffrey Willis
Director - Branded Distributed Business Unit · since 2012
Senior Independent Non-Executive Director · since 2010
Peter M. Steinmann
Non-Executive Independent Director · since 2013
IPO date
Apr 30, 2002
Employees
800
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
PREMIER PARK, 33 ROAD ONE
WINSFORD INDUSTRIAL ESTATE
WINSFORD, CHW CW7 3RT
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT